Carregant...
Challenges in the clinical assessment of novel tuberculosis drugs
To effectively tackle the global TB epidemic, novel treatment strategies are critically needed to shorten the duration of TB therapy and treat drug-resistant TB. Drug development for TB, stymied for decades, has enjoyed a renaissance over the past several years. However, development of new TB regime...
Guardat en:
| Publicat a: | Adv Drug Deliv Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4903928/ https://ncbi.nlm.nih.gov/pubmed/26827911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2016.01.014 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|